Total Payments
$550,068
2024 Payments
$70,434
Companies
24
Transactions
1,454
Medicare Patients
4,824
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$451,950 (82.2%)
Consulting$40,189 (7.3%)
Food & Beverage$39,026 (7.1%)
Travel$17,679 (3.2%)
Research$914.12 (0.2%)
Education$310.01 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $451,950 | 217 | 82.2% |
| Consulting Fee | $40,189 | 11 | 7.3% |
| Food and Beverage | $39,026 | 1,140 | 7.1% |
| Travel and Lodging | $17,679 | 72 | 3.2% |
| Unspecified | $914.12 | 5 | 0.2% |
| Education | $310.01 | 9 | 0.1% |
Payments by Type
General
$549,154
1,449 transactions
Research
$914.12
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $203,572 | 261 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $135,647 | 282 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $92,352 | 204 | $0 (2024) |
| ITI, Inc. | $33,679 | 57 | $0 (2023) |
| Axsome Therapeutics, Inc. | $14,713 | 23 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14,374 | 22 | $0 (2024) |
| Indivior Inc. | $13,185 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $11,885 | 89 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $8,502 | 57 | $0 (2024) |
| ABBVIE INC. | $6,449 | 60 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70,434 | 159 | Otsuka America Pharmaceutical, Inc. ($19,305) |
| 2023 | $67,983 | 157 | Alkermes, Inc. ($31,960) |
| 2022 | $72,655 | 168 | Alkermes, Inc. ($21,782) |
| 2021 | $60,336 | 179 | Neurocrine Biosciences, Inc. ($28,922) |
| 2020 | $41,490 | 168 | Alkermes, Inc. ($16,126) |
| 2019 | $97,602 | 257 | Alkermes, Inc. ($42,262) |
| 2018 | $76,896 | 190 | Alkermes, Inc. ($36,654) |
| 2017 | $62,672 | 176 | Alkermes, Inc. ($26,516) |
All Payment Transactions
1,454 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $79.18 | General |
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $41.34 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: CNS | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Neurology | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: CNS | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $423.61 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $249.66 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $55.49 | General |
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.86 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $38.82 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/30/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: CNS | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: PSYCHIATRY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial | Otsuka Pharmaceutical Development & Commercialization, Inc. | $914.12 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,055 | 5,057 | $584,952 | $395,767 |
| 2022 | 8 | 967 | 4,982 | $581,963 | $392,138 |
| 2021 | 9 | 1,308 | 5,229 | $621,847 | $423,870 |
| 2020 | 8 | 1,494 | 4,732 | $527,442 | $332,482 |
Total Patients
4,824
Total Services
20,000
Medicare Billing
$1.5M
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 416 | 2,804 | $304,216 | $219,466 | 72.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 1,223 | $155,921 | $96,661 | 62.0% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 82 | 355 | $41,817 | $22,042 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 193 | $31,049 | $21,581 | 69.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 82 | 85 | $20,155 | $14,278 | 70.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 19 | 97 | $10,994 | $8,270 | 75.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 58 | 100 | $8,080 | $5,987 | 74.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 34 | 47 | $7,779 | $5,538 | 71.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 153 | $4,941 | $1,945 | 39.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 426 | 3,018 | $334,046 | $237,572 | 71.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 292 | 1,095 | $147,412 | $89,132 | 60.5% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 80 | 407 | $44,172 | $27,649 | 62.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 163 | $26,780 | $18,053 | 67.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 48 | 49 | $12,639 | $8,080 | 63.9% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 15 | 80 | $9,327 | $7,062 | 75.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 36 | 49 | $4,302 | $3,022 | 70.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 121 | $3,284 | $1,569 | 47.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 583 | 2,273 | $279,779 | $182,280 | 65.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 430 | 1,911 | $216,644 | $159,924 | 73.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 264 | $46,439 | $30,018 | 64.6% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 89 | 422 | $44,284 | $28,530 | 64.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 74 | 74 | $18,516 | $12,013 | 64.9% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 16 | 73 | $8,583 | $6,653 | 77.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 23 | $3,363 | $2,473 | 73.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 20 | 145 | $3,578 | $1,847 | 51.6% |
About Isak Isakov
Isak Isakov is a Psychiatry healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770521775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Isak Isakov has received a total of $550,068 in payments from pharmaceutical and medical device companies, with $70,434 received in 2024. These payments were reported across 1,454 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($451,950).
As a Medicare-enrolled provider, Isakov has provided services to 4,824 Medicare beneficiaries, totaling 20,000 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Forest Hills, NY
- Active Since 06/02/2006
- Last Updated 08/28/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1770521775
Products in Payments
- INGREZZA (Drug) $92,352
- ARISTADA (Drug) $91,352
- ABILIFY MAINTENA (Drug) $85,627
- Aristada 441 mg (Drug) $63,128
- REXULTI (Drug) $48,938
- LYBALVI (Drug) $48,865
- CAPLYTA (Drug) $48,053
- Auvelity (Drug) $14,713
- PERSERIS (Drug) $13,093
- Trintellix (Drug) $11,475
- SPRAVATO (Drug) $10,599
- VRAYLAR (Drug) $6,586
- UZEDY (Drug) $4,710
- ABILIFY ASIMTUFII (Drug) $2,726
- LATUDA (Drug) $1,097
- BREXPIPRAZOLE (Drug) $914.12
- INVEGA SUSTENNA (Drug) $869.95
- AUSTEDO (Drug) $676.60
- TRINTELLIX (Drug) $479.08
- INVEGA TRINZA (Drug) $410.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Forest Hills
Leonid Izrayelit, Md, MD
Psychiatry — Payments: $6,400
Psychiatry $6,400
Yu Yang, M.d, M.D
Psychiatry — Payments: $4,416
Psychiatry $4,416
Shama Rasool, Md, MD
Psychiatry — Payments: $2,008
Psychiatry $2,008
Gary Weinstein, Md, MD
Psychiatry — Payments: $1,580
Psychiatry $1,580
Dr. Lober Cervantes, Md, MD
Psychiatry — Payments: $1,167
Psychiatry $1,167
Dr. Ebby Ohebshalom, M.d, M.D
Psychiatry — Payments: $890.78
Psychiatry $890.78